Chemically Modified TPO mRNA Boosts Platelet Production in M
2026-06-19
The referenced study demonstrates that in vitro-transcribed, chemically modified mRNA encoding thrombopoietin (TPO) can robustly stimulate platelet production in mice after lipid nanoparticle-mediated delivery. This work establishes mRNA-based TPO therapy as a promising, mechanistically distinct approach for treating thrombocytopenia, with implications for the design of next-generation mRNA therapeutics.
Serotonin Inhibits HRP-Mediated Proximity Labeling: Mechanis
2026-06-18
This study reveals that serotonin selectively inhibits HRP-catalyzed proximity labeling using membrane-impermeant biotinylated tyramide probes, a previously unrecognized confounder in neuronal proteomics. The authors demonstrate that serotonin, but not dopamine, suppresses biotinylation, and introduce a chemical strategy to restore labeling efficacy, thus refining experimental design for spatial proteomics in neuroscience.
Aztreonam: Advanced Mechanistic Insights and Research Protoc
2026-06-18
Explore the multifaceted scientific applications of Aztreonam, a monocyclic β-lactam antibiotic, with a focus on its molecular action, unique effects on hepatic enzymes, and protocol optimization for Gram-negative research. Distinct from existing resources, this article delivers actionable, evidence-grounded guidance for experimentalists.
Palonosetron Hydrochloride: Precision 5-HT3 Receptor Antagon
2026-06-17
Palonosetron hydrochloride sets the benchmark for 5-HT3 receptor antagonist research, combining nanomolar potency, dual-site allosteric action, and unrivaled selectivity. Explore optimal applications in CINV/RINV modeling, renal transporter inhibition, and stepwise troubleshooting—empowering oncology and pharmacology labs with superior reproducibility.
Levofloxacin in Research: Applied Workflows and Resistance I
2026-06-17
Levofloxacin, a synthetic fluoroquinolone antibiotic, empowers researchers to dissect bacterial DNA replication and explore bone and cartilage metabolism with precision. This guide delivers practical workflows, troubleshooting strategies, and integrates new resistance findings to help optimize both microbiological and cell-based assays.
Vemurafenib (PLX4032): Systems Biology Insights for Melanoma
2026-06-16
Explore how Vemurafenib (PLX4032) advances melanoma cell proliferation inhibition and resistance analysis. This article uniquely integrates multi-omics findings and practical assay considerations for cancer biology research.
Clarithromycin as a CYP3A Inhibitor: Advanced DDI Workflow G
2026-06-16
Clarithromycin, a potent CYP3A inhibitor, is an essential tool for mechanistic pharmacokinetic and drug-drug interaction (DDI) research, particularly in cardiovascular and metabolic contexts. This article delivers a practical, protocol-driven guide for optimizing Clarithromycin-based workflows, drawing on the latest evidence to ensure reproducible results and actionable insights.
Quercetin as a PI3K Inhibitor: Experimental Workflows & Opti
2026-06-15
Quercetin is redefining PI3K inhibition in cancer and liver injury research, offering robust, reproducible modulation of cell death pathways. Explore applied protocols, advanced troubleshooting, and key translational insights that set APExBIO's Quercetin apart for modern biomedical assays.
Levofloxacin in Research: Beyond Antibacterial Action to Bon
2026-06-15
Explore how Levofloxacin, a synthetic fluoroquinolone antibiotic, is redefining advanced research into bacterial DNA replication and bone/cartilage metabolism. This article uniquely integrates recent multidrug resistance insights with practical assay considerations for scientific investigators.
ERADECs: Small-Molecule Hijacking of ERAD for TM Protein Deg
2026-06-14
Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that leverages the endoplasmic reticulum-associated degradation (ERAD) pathway to selectively degrade transmembrane proteins. This breakthrough addresses long-standing barriers in targeted protein degradation and opens new directions for research in membrane protein modulation and disease intervention.
Oral Gepotidacin in Urogenital Gonorrhoea: Phase 3 Evidence
2026-06-13
The EAGLE-1 phase 3 trial establishes oral gepotidacin as a non-inferior alternative to standard dual therapy for uncomplicated urogenital gonorrhoea. This work advances the clinical landscape by demonstrating high microbiological cure rates and a manageable safety profile, paving the way for new oral treatment options amid rising antimicrobial resistance.
Faropenem Sodium: Penem Antibiotic Workflows for AMR Researc
2026-06-12
Faropenem sodium stands out as a penem antibiotic with remarkable oral bioavailability and unmatched activity across Gram-positive, Gram-negative, and anaerobic bacteria, making it invaluable for antimicrobial resistance (AMR) research. This article provides actionable protocols, troubleshooting insights, and an evidence-based outlook to help researchers leverage Faropenem sodium for advanced infection modeling and resistance studies.
Liproxstatin-1 HCl: Elevating Ferroptosis Research for Trans
2026-06-12
Explore how Liproxstatin-1 HCl advances the dissection of ferroptosis mechanisms, integrates with cutting-edge discoveries in mitochondrial calcium signaling, and provides translational researchers with a strategic foundation for modeling and modulating iron-dependent cell death in acute organ injury and cancer.
Angiotensin III: Mechanistic Insights Empowering RAAS Resear
2026-06-11
Explore the evolving role of Angiotensin III in RAAS signaling, experimental modeling, and translational pipelines. This article blends mechanistic depth with actionable guidance for researchers, contextualizes recent findings on angiotensin peptides and viral pathogenesis, and positions APExBIO’s Angiotensin III (human, mouse) as a gold-standard tool for cardiovascular and neuroendocrine studies.
Open Platform DLP Enables Precision Hydrogel Printing in 96-
2026-06-11
The reference study introduces a low-cost, open platform digital light printer (OP-DLP) for high-throughput, spatially controlled hydrogel fabrication in standard 96-well plates. This innovation streamlines localized light-activation and hydrogel patterning, enhancing reproducibility and flexibility for biomaterials and cell-based research.
510 records 18/34 page Previous Next First page 上5页 1617181920 下5页 Last page